Zusammenfassung
Hintergrund
Die akute Exazerbation einer idiopathischen interstitiellen Pneumonie wie auch von interstitiellen Pneumonien im Rahmen von Systemerkrankungen ist mit einer hohen Mortalität verbunden.
Diagnostik
Differenzialdiagnostisch gilt es diese von respiratorischen Verschlechterungen einer interstitiellen Pneumonie als Folge von Infektionen, Lungenembolien, Linksherzerkrankungen und Medikamentennebenwirkungen abzugrenzen, da letztere kausal therapiert werden können. Der Umfang und die Invasivität der Diagnostik müssen sich am klinischen Zustand des Patienten orientieren. Eine rasche Diagnostik ist wichtig, damit eine Therapie (Antibiose, Antikoagulation, Immunsuppresion) im Fall behandelbarer Exazerbationsursachen zeitnah eingeleitet werden kann.
Stellenwert der Beatmung
Die Prognose für invasiv beatmete Patienten mit akuter Exazerbation einer interstitiellen Pneumonie ist schlecht. Für die primäre akute Exazerbation einer idiopathischen pulmonalen Fibrose (IPF) kann keine generelle Empfehlung zur invasiven oder nichtinvasiven Beatmung ausgesprochen werden. Bei akuter Exazerbation einer anderen Form der interstitiellen Pneumonie, sei sie idiopathisch oder im Rahmen einer Systemerkrankung, oder bei Vorliegen einer sekundären Exazerbation einer idiopathischen interstitiellen Pneumonie mit behandelbarer Ursache ist der Stellenwert der Beatmung differenzierter zu betrachten.
Lungentransplantation
Insbesondere bei jüngeren Patienten mit prognostisch ungünstigen interstitiellen Lungenerkrankungen sollte frühzeitig und noch vor einer Exazerbation eine Entscheidung über die Indikation zur Lungentransplantation getroffen werden. Bei akuter Exazerbation während der Wartezeit auf eine Lungentransplantation sind mit dem Transplantationszentrum extrakorporale Verfahren als Bridging-to-transplant-Maßnahm zu klären. Bei infauster Prognose sind palliative Therapiekonzepte einzusetzen.
Abstract
Background
Acute exacerbations of idiopathic interstitial pneumonias and exacerbations of pleuropulmonary disease in connective tissue diseases are associated with a high mortality.
Diagnostic procedures
They have to be differentiated from respiratory failure in patients with interstitial lung disease as a result of infections, pulmonary embolism, cardiac failure and drug toxicity, because the latter can be treated causally. The extent and the invasivity of diagnostic procedures have to be adopted to the patient’s situation. A rapid diagnosis is important in order to initiate therapies (antibiotics, anticoagulation, immunosuppression) in treatable causes of exacerbations.
Importance of ventilation
The prognosis for patients who are under invasive mechanical ventilation in acute exacerbations of interstitial lung disease is poor. Especially in acute exacerbations of idiopathic pulmonary fibrosis (IPF), there is no general recommendation for either invasive or for noninvasive ventilation. In acute exacerbations of other subtypes of interstitial pneumonia, either idiopathic or as a pulmonary manifestation of connective tissue disease, and in all secondary exacerbations of idiopathic interstitial pneumonias which offer further treatment options, the decision about mechanical ventilation requires a differentiated assessment.
Lung transplantation
In younger patients with interstitial lung disease and a progressive disease, indication for lung transplantation should be made early and before an exacerbation. If patients listed for lung transplantation experience an acute exacerbation, bridging-to-transplant has to be discussed with the transplant unit. In cases without further causal treatment options palliative care must be initiated.
Literatur
Antoniou KM, Margaritopoulos G, Economidou F et al (2009) Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 33:882–896
Baydur A (2008) Mechanical ventilation in interstitial lung disease: which patients are likely to benefit? Chest 133:1062–1063
Biener I, Czaplik M, Bickenbach J et al (2013) Lungenprotektive Beatmung bei ARDS. Med Klin Intensivmed Notfmed 108:578–583
Boyer A, Vargas F, Delacre M et al (2011) Prognostic impact of high-flow nasal cannula oxygen supply in an ICU patient with pulmonary fibrosis complicated by acute respiratory failure. Intensive Care Med 37:558–559
Churg A, Müller NL, Silva CI et al (2007) Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 31:277–284
Churg A, Wright JL, Tazelaar HD (2011) Acute exacerbations of fibrotic interstitial lung disease. Histopathology 58:525–530
Collard HR, Moore BB, Flaherty KR et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176:636–643
Lauretis A de, Veeraraghavan S, Renzoni E (2011) Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 8:53–82
Fernandez-Pérez ER, Yilmaz M, Jenad H et al (2008) Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 133:1113–1119
Gaudry S, Vincent F, Rabbat A et al (2014) Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J Thorac Cardiovasc Surg 147:47–53
Ghatol A, Ruhl AP, Danoff SK (2012) Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung 190:373–380
Güngör G, Tatar D, Saltürk C et al (2013) Why do patients with interstitial lung diseases fail in the ICU? A two-center cohort study. Respir Care 58:525–531
Hoopes CW, Kukreja J, Golden J, Davenport DL et al (2013) Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg 145:862–867
Hyzy R, Huang S, Myers J et al (2007) Acute exacerbation of idiopathic pulmonary fibrosis. Chest 132:1652–1658
Leslie KO, Trahan S, Gruden J (2007) Pulmonary pathology of the rheumatic diseases. Sem Respir Crit Care Med 28:369–378
Kamata Y, Nara H, Kamimura T et al (2004) Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 43:1201–1204
Kameda H, Tokuda H, Sakai F et al (2011) Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. Intern Med 50:305–313
Kim EJ, Collard HR, King TE (2009) Rheumatoid arthritis-associated interstitial lung disease. Chest 136:1397–1405
Kim EJ, Elicker BM, Maldonado F et al (2010) Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35:1322–1328
Kishaba T, Shimaoka Y, Fukuyama H et al (2012) A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. BMJ Open 2(3)
Kishaba T, Tamaki H, Shimaoka Y et al (2013) Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung (Epub ahead of print)
Mollica C, Paone G, Conti V et al (2010) Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration 79:209–215
Morawiec E, Tillie-Leblond I, Pansini V et al (2011) Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroid and cyclophsophamid pulses. Eur Respir J 38:1487–1489
Mukhopadhyay S, Parambil JG (2012) Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS). Semin Respir Crit Care Med 33:476–485
Mura M, Porretta MA, Bargagli E et al (2012) Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J 40:101–109
National Institute for Health and Care Excellence (2013) Idiopathic pulmonary fibrosis. The diagnosis and management of suspected idiopathic pulmonary fibrosis. NICE clinical guideline 163. http://www.nice.org.uk/guidance/cg163. Zugegriffen: 07.07.2014
Nosotti M, Rosso L, Tosi D et al (2013) Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation. Interact Cardiovasc Thorac Surg 16:55–59
Park IN, Kim DS, Shim TS et al (2007) Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132:214–220
Peters SG, Holets SR, Gay PC (2013) High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir Care 58:597–600
Pinsky MR (1986) Cardiopulmonary interaction – the effects of negative and positive pleural pressure changes on cardiac output. In: Dantzker DR (Hrsg) Cardiopulmonary critical care. Grune and Stratton, Orlando, S 89–121
Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824
Ryerson CJ, Hartman T, Elicker BM et al (2013) Clinical features and outcomes in combined pulmo-nary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 144:234–240
Sakamoto K, Taniguchi H, Kondoh Y et al (2012) Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures. Respir Med 106:436–442
Saydain G, Islam A, Afessa B et al (2002) Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 166:839–842
Schneider F, Gruden J, Tazelaar HD et al (2012) Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 136:1242–1252
Schönhofer B, Kuhlen R, Neumann P et al (2008) Nichtinvasive Beatmung als Therapie der akuten respiratorischen Insuffizienz.S3-Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 62:449–479
Simon-Blancal V, Freynet O, Nunes H et al (2012) Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration 83:28–35
Song JW, Hong SB, Lim CM et al (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356–363
Suda T, Kono M, Nakamura Y et al (2010) Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med 104:1527–1534
Tachikawa R, Tomii K, Ueda H et al (2012) Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 83:20–27
Tomii K, Tachikawa R, Chin K et al (2010) Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Inter Med 49:1341–1347
The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733–748
Vial-Dupuy A, Sanchez O, Douvry et al (2013) Outcome of patients with interstitial lung disease admitted to the intensive care unit. Sarcoidosis Vasc Diffuse Lung Dis 30:134–142
Vij R, Strek ME (2011) Autoimmune-Featured interstitial lung disease: a distinct entity. Chest 140:1292–1299
Vij R, Strek ME (2013) Diagnosis and treatment of conncetive tissue disease-associated interstitial lung disease. Chest 143:814–824
Yokoyama T, Kondoh Y, Taniguchi H (2010) Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 49:1509–1514
Yokoyama T, Tsushimata K, Yamamoto H (2012) Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive interstitial pneumonia. Respirology 17:315–321
Einhaltung ethischer Richtlinien
Interessenkonflikt. M. Westhoff gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Westhoff, M. Akut-auf-chronisches respiratorisches Versagen bei interstitiellen Pneumonien. Med Klin Intensivmed Notfmed 110, 188–196 (2015). https://doi.org/10.1007/s00063-014-0388-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-014-0388-6